Subscribe To
The ratings game: amd's strong rally could cool amid potential ‘fatigue' in pc market, analyst says in downgrade
Following a strong rally in recent years, Advanced Micro Devices Inc. shares could to face a tougher stretch ahead amid signs of fundamental “fatigu...
January 20, 2022, 11:22 am
Amd stock price predictions: why this analyst just lowered his target on advanced micro devices
Advanced Micro Devices (AMD) stock is slipping on Thursday following a new price prediction from Piper Sandler analyst Harsh Kumar. The post AMD Stock...
January 20, 2022, 10:54 am
Amd stock price predictions: why this analyst just lowered his target on advanced micro devices
Advanced Micro Devices (AMD) stock is slipping on Thursday following a new price prediction from Piper Sandler analyst Harsh Kumar. The post AMD Stock...
January 20, 2022, 10:54 am
Amd stock price predictions: why this analyst just lowered his target on advanced micro devices
Advanced Micro Devices (AMD) stock is slipping on Thursday following a new price prediction from Piper Sandler analyst Harsh Kumar. The post AMD Stock...
January 20, 2022, 10:54 am
Fda clears turning point's ind for elzovantinib + aumolertinib combo regime in lung cancer setting
The FDA has signed off Turning Point Therapeutics Inc's (NASDAQ: TPTX) Investigational New Drug (IND) application for elzovantinib + aumolertinib c...
January 20, 2022, 10:36 am
Fda clears turning point's ind for elzovantinib + aumolertinib combo regime in lung cancer setting
The FDA has signed off Turning Point Therapeutics Inc's (NASDAQ: TPTX) Investigational New Drug (IND) application for elzovantinib + aumolertinib c...
January 20, 2022, 10:36 am
Fda clears turning point's ind for elzovantinib + aumolertinib combo regime in lung cancer setting
The FDA has signed off Turning Point Therapeutics Inc's (NASDAQ: TPTX) Investigational New Drug (IND) application for elzovantinib + aumolertinib c...
January 20, 2022, 10:36 am
Catalent (ctlt) to advance oral drug development with new launch
Catalent's (CTLT) Xpress Pharmaceutics service offers a quicker alternative to the traditional clinical development model, lowering the time needed to...
January 20, 2022, 9:59 am
Catalent (ctlt) to advance oral drug development with new launch
Catalent's (CTLT) Xpress Pharmaceutics service offers a quicker alternative to the traditional clinical development model, lowering the time needed to...
January 20, 2022, 9:59 am
Catalent (ctlt) to advance oral drug development with new launch
Catalent's (CTLT) Xpress Pharmaceutics service offers a quicker alternative to the traditional clinical development model, lowering the time needed to...
January 20, 2022, 9:59 am
Should you buy advanced micro devices (amd) ahead of earnings?
Advanced Micro Devices (AMD) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings seaso...
January 20, 2022, 9:59 am
Should you buy advanced micro devices (amd) ahead of earnings?
Advanced Micro Devices (AMD) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings seaso...
January 20, 2022, 9:59 am
Should you buy advanced micro devices (amd) ahead of earnings?
Advanced Micro Devices (AMD) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings seaso...
January 20, 2022, 9:59 am
Sorrento therapeutics' covid-19 antibody works against omicron variant
Sorrento Therapeutics Inc (NASDAQ: SRNE) has released new data on STI-9167, an advanced stage antibody against COVID-19. The antibody was discovered...
January 20, 2022, 9:25 am
Sorrento therapeutics' covid-19 antibody works against omicron variant
Sorrento Therapeutics Inc (NASDAQ: SRNE) has released new data on STI-9167, an advanced stage antibody against COVID-19. The antibody was discovered...
January 20, 2022, 9:25 am
Sorrento therapeutics' covid-19 antibody works against omicron variant
Sorrento Therapeutics Inc (NASDAQ: SRNE) has released new data on STI-9167, an advanced stage antibody against COVID-19. The antibody was discovered...
January 20, 2022, 9:25 am
Amgen's lumakras approved in japan for pretreated lung cancer patients
Amgen Inc's (NASDAQ: AMGN) Lumakras (sotorasib) has been approved in Japan for KRAS G12C-mutated positive, unresectable, advanced and/or recurrent ...
January 20, 2022, 8:52 am
Amgen's lumakras approved in japan for pretreated lung cancer patients
Amgen Inc's (NASDAQ: AMGN) Lumakras (sotorasib) has been approved in Japan for KRAS G12C-mutated positive, unresectable, advanced and/or recurrent ...
January 20, 2022, 8:52 am
Amgen's lumakras approved in japan for pretreated lung cancer patients
Amgen Inc's (NASDAQ: AMGN) Lumakras (sotorasib) has been approved in Japan for KRAS G12C-mutated positive, unresectable, advanced and/or recurrent ...
January 20, 2022, 8:52 am
Fda clears nuvation bio's ind application for nuv-868 in advanced solid tumors
The FDA has signed off Nuvation Bio Inc's (NYSE: NUVB) investigational new drug (IND) application to evaluate NUV-868 to treat advanced solid tumor...
January 20, 2022, 8:43 am